The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ARCUTIS BIOTHERAPEUTICS INC COM 03969K108   123,690 5,250 SH   SOLE   5,250 0 0
ARDELYX INC COM 039697107   770,614 128,650 SH   SOLE   128,650 0 0
AZENTA INC COM 114340102   204,961 9,700 SH   SOLE   9,700 0 0
BENITEC BIOPHARMA INC COM NEW 08205P209   660,300 62,000 SH   SOLE   62,000 0 0
BIOHAVEN LTD COM G1110E107   437,382 51,700 SH   SOLE   51,700 0 0
BRIDGEBIO PHARMA INC COM 10806X102   371,300 5,000 SH   SOLE   5,000 0 0
COMPASS PATHWAYS PLC SPONSORED ADS 20451W101   442,400 80,000 SH   SOLE   80,000 0 0
CUE BIOPHARMA INC COM 22978P106   506,436 2,202,854 SH   SOLE   2,202,854 0 0
DISC MEDICINE INC COM 254604101   517,914 8,100 SH   SOLE   8,100 0 0
DYNE THERAPEUTICS INC COM 26818M108   326,340 18,000 SH   SOLE   18,000 0 0
EDGEWISE THERAPEUTICS INC COM 28036F105   286,650 9,100 SH   SOLE   9,100 0 0
FENNEC PHARMACEUTICALS INC COM 31447P100   691,469 112,434 SH   SOLE   112,434 0 0
GERON CORP COM 374163103   861,220 578,000 SH   SOLE   578,000 0 0
GH RESEARCH PLC ORDINARY SHARES G3855L106   143,412 10,200 SH   SOLE   10,200 0 0
HUMACYTE INC COM 44486Q103   394,355 650,000 SH   SOLE   650,000 0 0
INNATE PHARMA S A SPONSORED ADS 45781K204   103,873 81,151 SH   SOLE   81,151 0 0
INNOVIVA INC COM 45781M101   191,060 8,200 SH   SOLE   8,200 0 0
JANUX THERAPEUTICS INC COM 47103J105   264,100 19,000 SH   SOLE   19,000 0 0
JASPER THERAPEUTICS INC COM NEW 471871202   407,433 465,000 SH   SOLE   465,000 0 0
KURA ONCOLOGY INC COM 50127T109   373,980 46,000 SH   SOLE   46,000 0 0
LANTHEUS HLDGS INC COM 516544103   417,175 5,500 SH   SOLE   5,500 0 0
MILESTONE PHARMACEUTICALS IN COM 59935V107   975,800 820,000 SH   SOLE   820,000 0 0
MINERALYS THERAPEUTICS INC COM 603170101   284,445 10,500 SH   SOLE   10,500 0 0
MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD 61559X104   1,258,200 67,500 SH   SOLE   67,500 0 0
PACIRA BIOSCIENCES INC COM 695127100   305,100 13,500 SH   SOLE   13,500 0 0
PRAXIS PRECISION MEDICINES I COM NEW 74006W207   1,433,746 4,450 SH   SOLE   4,450 0 0
REGENXBIO INC COM 75901B107   222,908 26,600 SH   SOLE   26,600 0 0
ROCKET PHARMACEUTICALS INC COM 77313F106   307,880 86,000 SH   SOLE   86,000 0 0
ROYALTY PHARMA PLC SHS CLASS A G7709Q104   1,026,558 21,400 SH   SOLE   21,400 0 0
SAREPTA THERAPEUTICS INC COM 803607100   620,160 28,500 SH   SOLE   28,500 0 0
SERES THERAPEUTICS INC COM NEW 81750R201   280,026 31,570 SH   SOLE   31,570 0 0
SPRUCE BIOSCIENCES INC COM NEW 85209E208   65,350 1,000 SH   SOLE   1,000 0 0
SYNDAX PHARMACEUTICALS INC COM 87164F105   840,960 36,000 SH   SOLE   36,000 0 0
UNIQURE NV SHS N90064101   240,345 14,700 SH   SOLE   14,700 0 0
VIATRIS INC COM 92556V106   374,227 27,700 SH   SOLE   27,700 0 0